CEO

Dr. Vleugels received MA in Economics (University of Texas at Austin, 1984) and completed his PhD in Policy Sciences at Radboud University Nijmegen in 1990. He worked as technology transfer officer for the Medical Faculty of the Maastricht University, where he was one of the founders of the Biopartner valorization programme to generate start-up companies. In 1996, Dr. Vleugels founded MUbio Products with Prof. Frans Ramaekers. Dr. Vleugels was the managing director till 2010. He also founded NovoVacs which merged with MUbio in 2006. In 2012, Dr. Vleugels co-founded CyTuVax with Prof. Frank Falkenberg.